BioPharm
I N T E R N AT I O N A L
eBook
T h e S ci e n ce & B usi n e ss o f B i o p h a r m a ce u ti c a ls
FOUNDER
Mike Hennessy Sr
1960 - 2021
© 2025 MultiMedia Pharma Sciences LLC All rights reserved. No part of this publication may be reproduced or
transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information
storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/
educational or personal use, or the internal/educational or personal use of specific clients is granted by MultiMedia
Pharma Sciences LLC for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr.
Danvers, MA 01923, 978-750-8400 fax 978-646-8700 or visit http://www.copyright.com online.
MultiMedia Pharma Sciences LLC provides certain customer contact data (such as customers' names,
addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services,
and other opportunities that may be of interest to you. If you do not want MultiMedia Pharma Sciences LLC to
make your contact information available to third parties for marketing purposes, simply email customerservice@
mjhlifesciences.com and a customer service representative will assist you in removing your name from MultiMedia
Pharma Sciences LLC lists.
BioPharm International
®
does not verify any claims or other information appearing in any of the advertisements
contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in
reliance of such content.
BioPharm International welcomes unsolicited articles, manuscripts, photographs, illustrations, and other materials
but cannot be held responsible for their safekeeping or return.
To subscribe, email customerservice@mjhlifesciences.com
Contents
EDITORIAL
Vice President, Content Alicia Bigica ABigica@mjhlifesciences.com
Lead Editor Susan Haigney SHaigney@mjhlifesciences.com
Editor Feliza Mirasol FMirasol@mjhlifesciences.com
Editor Patrick Lavery PLavery@mjhlifesciences.com
Design and Production
Creative Director Robert McGarr rmcgarr@mjhlifesciences.com
Associate Creative Director Kristen Morabito kmorabito@mjhlifesciences.com
Print and Circulation Director Jonathan Severn jsevern@mjhassoc.com
Production Manager Charlton Prince cprince@mjhlifesciences.com
Print Production Coordinator Amber Immordino ammordino@mjhassoc.com
CUSTOM CONTENT
Senior Custom Content Manager Jeanne Linke Northrop
Custom Content Specialist Megan Manzano
Custom Content Specialist Shannon Stolz
SALES
Executive Vice President, Healthcare and Industry Sciences Brian Haug
National Sales Manager Scott Vail SVail@mjhlifesciences.com
Sales Manager Joel Kern JKern@mjhlifesciences.com
National Accounts Associate Alex Bryant abryant@mjhlifesciences.com
European Sales Manager Linda Hewitt LHewitt@mjhlifesciences.com
European Senior Sales Executive Stephen Cleland
SCleland@mjhlifesciences.com
Director, Industry Relations and Strategic Partnerships Chris Spivey
CSpivey@mjhlifesciences.com
MJH LIFE SCIENCES
®
President & CEO Mike Hennessy Jr
Chief Financial Officer Neil Glasser, CPA/CFE
Chief Operating Officer Beth Buehler
Chief Brand Officer Silas Inman
Chief Data Officer Terric Townsend
Executive Vice President, Global Medical Affairs
& Corporate Development Joe Petroziello
Senior Vice President, Human Resources
& Administration Shari Lundenberg
Senior Vice President, Mergers & Acquisitions,
Strategic Innovation Phil Talamo
Executive Creative Director Jeff Brown
Next-Generation Biotherapeutics
eBook April 2025
Cover: bulegendut – Stock.Adobe.com
INNOVATION
Emerging Modalities and Strategic
Innovation in the Biopharma R&D
Landscape
Feliza Mirasol
The biopharmaceutical landscape is undergoing
a huge shift from traditional therapies to more
specialty-driven modalities. 4
ONCOLOGY
Emerging Treatments for Cancer
Susan Haigney
CAR T-cell therapies, TILs, and other advanced
therapies are pushing progress in the treatment of cancers. 8
TRANSFER RNA
TRNA: Little Cousin, Big Potential
Patrick Lavery
Transfer RNA is being investigated as a
treatment for as many as 400 rare and
ultra-rare diseases affecting the liver. 14
INDUSTRY UPDATE
Biotherapeutics Partnerships
and Innovation Expanding
Patrick Lavery
Groundbreaking clinical studies and new
research collaborations are pushing ahead
even as uncertainty lingers about the geopolitical
climate's impact on development. 18
www.biopharminternational.com Next-Generation Biotherapeutics April 2025 BioPharm International
®
3
Eppendorf ...................................................................................... 17
Fresenius Kabi ................................................................................. 9
Halo Labs ........................................................................................ 13
Intertek ............................................................................................. 2
Veltek Associates ............................................................................ 5
Ad Index
COMPANY PAGE
